The risk of CRC in adults with CF is 5–10 times greater compared to the general population and it is estimated that 25% of patients with CF will develop advanced adenomas, with a risk also extended to carriers of CFTR mutations [29]. The gene discussed is CFTR; the disease is cystic fibrosis.